PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression

Cyclic AMP–dependent protein kinase A (PKA) and protein phosphatase 1 (PP1) are proteins involved in numerous essential signalling pathways that modulate physiological and pathological functions. Both PP1 and PKA can be inhibited by dopamine‐ and cAMP‐regulated phosphoprotein 32 kD (DARPP‐32). Using immunohistochemistry, PKA and PP1 expression was determined in a large primary breast tumour cohort to evaluate associations between clinical outcome and clinicopathological criteria (n > 1100). In addition, mRNA expression of PKA and PP1 subunits was assessed in the METABRIC data set (n = 1980). Low protein expression of PKA was significantly associated with adverse survival of breast cancer patients; interestingly, this relationship was stronger in ER‐positive breast cancer patients. PP1 protein expression was not associated with patient survival. PKA and PP1 subunit mRNA was also assessed; PPP1CA, PRKACG and PRKAR1B were associated with breast cancer–specific survival. In patients with high expression of DARPP‐32, low expression of PP1 was associated with adverse survival when compared to high expression in the same group. PKA expression and PP1 expression are of significant interest in cancer as they are involved in a wide array of cellular processes, and these data indicate PKA and PP1 may play an important role in patient outcome.

[1]  T. Starr,et al.  Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. , 2020, Gastroenterology.

[2]  Song Yang,et al.  Dopamine and cAMP‐regulated phosphoprotein 32kDa (DARPP‐32), protein phosphatase‐1 and cyclin‐dependent kinase 5 expression in ovarian cancer , 2020, Journal of cellular and molecular medicine.

[3]  Luke H. Hoeppner,et al.  ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation , 2020, British Journal of Cancer.

[4]  I. Ellis,et al.  Retrospective assessment of cyclin‐dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer , 2020, Journal of cellular and molecular medicine.

[5]  Baochi Ou,et al.  USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway , 2019, EBioMedicine.

[6]  W. El-Rifai,et al.  Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells , 2019, Oncogene.

[7]  Carlos Conde,et al.  Phosphatases in Mitosis: Roles and Regulation , 2019, Biomolecules.

[8]  J. Momand,et al.  Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks. , 2019, Biochemical pharmacology.

[9]  P. Ruvolo.  Role of protein phosphatases in the cancer microenvironment. , 2019, Biochimica et biophysica acta. Molecular cell research.

[10]  Rui Huang,et al.  Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[11]  Luke H. Hoeppner,et al.  DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration , 2018, Communications Biology.

[12]  S. Kane,et al.  t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit. , 2017, Cellular signalling.

[13]  S. Kane,et al.  t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells , 2017, Clinical Cancer Research.

[14]  I. Durán,et al.  Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma , 2017, Oncotarget.

[15]  L. Paz-Ares,et al.  Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer , 2017, Oncotarget.

[16]  A. Carnero,et al.  Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors , 2016, Oncogene.

[17]  M. A. O. Ignacio,et al.  How to cite this article , 2016 .

[18]  M. Pujana,et al.  PKA signaling drives mammary tumorigenesis through Src , 2014, Oncogene.

[19]  W. Zwart,et al.  PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance , 2013, Oncogene.

[20]  J. Forrester,et al.  A Role for PP1/NIPP1 in Steering Migration of Human Cancer Cells , 2012, PloS one.

[21]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[22]  S. Kane,et al.  Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines , 2009, Clinical Cancer Research.

[23]  Irene L Andrulis,et al.  The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors , 2007, BMC Cancer.

[24]  D G Altman,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British journal of cancer.

[25]  Douglas G Altman,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK). , 2005, European journal of cancer.

[26]  A. Floore,et al.  Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer. , 2004, Cancer cell.

[27]  C. Moskaluk,et al.  Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. , 2002, Cancer research.

[28]  P. Greengard,et al.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons , 1999, Nature.

[29]  E. Villa-Moruzzi,et al.  Differential Subcellular Localization of Protein Phosphatase-1 α, γ1, and δ Isoforms during Both Interphase and Mitosis in Mammalian Cells , 1998, The Journal of cell biology.

[30]  P. Greengard,et al.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 , 1984, Nature.

[31]  Paul Greengard,et al.  A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions , 1983, Nature.